Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

Date: March 15, 2017
Pages: 104
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD7B10DE619EN
Leaflet:

Download PDF Leaflet

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review
Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pfizer Inc (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products in key therapeutic areas including internal medicine, cancer, vaccines, inflammation and immunology and rare diseases. It also provides sterile injectable pharmaceuticals, infusion systems, biosimilars, as well as active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in the US, Canada, Latin America, Asia, Japan, South Korea, New Zealand, Australia, Finland, Scandinavian countries, Africa, the Middle East and Turkey. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

Mar 08, 2017: The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients
Mar 06, 2017: Pfizer Selects Turner & Townsend For Expansion Of Its Clinical Research Unit In Belgium
Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer’s Board of Directors
Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results
Dec 20, 2016: Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Pfizer Inc - Key Facts
Pfizer Inc - Key Employees
Pfizer Inc - Key Employee Biographies
Pfizer Inc - Major Products and Services
Pfizer Inc - Pharmaceutical Pipeline Products Data
Pfizer Inc, Pipeline Products by Therapy Area
Pfizer Inc, Pipeline Products by Development Phase
Pfizer Inc - History
Pfizer Inc - Company Statement
Pfizer Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Pfizer Inc - Business Description
Pfizer Inc - Corporate Strategy
Pfizer Inc - SWOT Analysis
SWOT Analysis - Overview
Pfizer Inc - Strengths
Pfizer Inc - Weaknesses
Pfizer Inc - Opportunities
Pfizer Inc - Threats
Pfizer Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Pfizer Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 08, 2017: The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients
Mar 06, 2017: Pfizer Selects Turner & Townsend For Expansion Of Its Clinical Research Unit In Belgium
Feb 23, 2017: Ronald E. Blaylock Elected to Pfizer’s Board of Directors
Jan 31, 2017: Pfizer Reports Fourth-Quarter And Full-Year 2016 Results
Dec 20, 2016: Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes
Dec 12, 2016: Pioneers in Oncolytic Virus and Gene Therapy Fields Announce Formation of IGNITE Immunotherapy a Company Focused on Oncolytic Cancer Vaccine Discovery and Development
Dec 06, 2016: Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers
Dec 01, 2016: IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
Nov 21, 2016: Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire
Nov 11, 2016: Pfizer Announces Major Expansion of Humanitarian Assistance Program

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pfizer Inc, Key Facts
Pfizer Inc, Key Employees
Pfizer Inc, Key Employee Biographies
Pfizer Inc, Major Products and Services
Pfizer Inc, Number of Pipeline Products by Therapy Area
Pfizer Inc, Number of Pipeline Products by Development Stage
Pfizer Inc, History
Pfizer Inc, Subsidiaries
Pfizer Inc, Joint Venture
Pfizer Inc, Key Competitors
Pfizer Inc, Ratios based on current share price
Pfizer Inc, Annual Ratios
Pfizer Inc (Cont.1), Annual Ratios
Pfizer Inc, Interim Ratios
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Pfizer Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Pfizer Inc, Pipeline Products by Therapy Area
Pfizer Inc, Pipeline Products by Development Phase
Pfizer Inc, Performance Chart (2012 - 2016)
Pfizer Inc, Ratio Charts
Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sanofi
Novartis AG
Merck & Co Inc
Johnson & Johnson
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
AstraZeneca Plc
Amgen Inc
AbbVie Inc
Skip to top


Ask Your Question

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: